ronnie_meninger

Algatech gets new chief executive and chief scientist

pharmafile | February 24, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algatech, Ronnie Meninger, Sammy Boussiba 

Israel-based biotech Algatech has confirmed the appointment of Ronnie Meninger as its chief executive, and Sammy Boussiba as chief scientist.

Meninger (pictured) has more than 30 years of experience in the fine chemical, special ingredients and pharma industries. She has served in many managerial positions and was managing director of Chemada Fine chemicals, Israel (part of the ICL Group).

Meninger’s first strategic move was to nominate Boussiba from The Blaustein Institute for Desert Research as chief scientist to the firm. She says Boussiba is among the world’s leading scientists in microalgae biotechnology and the inventor of the technology used by Algatech for the AstaPure natural astaxanthin production.

Advertisement

“I’m excited to join Algatech and be part of its excellent team,” says Meninger.

“Boussiba’s nomination is important for our future success. Science is one of our company foundations and we aim to increase investment not only in innovation but also in new technologies, sustainable production and improved business models.”

“I’m very pleased to welcome Ronnie Meninger as the chief executive of Algatech,” says Ed Hofland, Algatech’s chairman. “I’m convinced that under Ronnie’s leadership Algatech will continue to grow and show strong performance based on its solid foundations and devoted team.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content